Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,013Revenue $M69.6Net Margin (%)-286.5Z-Score-5.4
Enterprise Value $M1,007EPS $-0.6Operating Margin %-257.7F-Score3
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-286.5Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %-11.5Quick Ratio2.2Cash flow > EarningsY
Price/Sales28.65-y EBITDA Growth Rate %-15.1Current Ratio2.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-68.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M132ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ARRY

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARRYJean-Marie Eveillard 2011-12-31 Sold Out -0.0024%$1.77 - $2.83
($2.28)
$ 7.81242%Sold Out0
ARRYGeorge Soros 2011-12-31 Sold Out -0.0008%$1.77 - $2.83
($2.28)
$ 7.81242%Sold Out0
ARRYGeorge Soros 2011-09-30 Buy $1.99 - $2.62
($2.24)
$ 7.81249%New holding, 22400 sh.22,400
ARRYGeorge Soros 2011-06-30 Sold Out $2.06 - $3.21
($2.7)
$ 7.81189%Sold Out0
ARRYJean-Marie Eveillard 2011-06-30 Add$2.06 - $3.21
($2.7)
$ 7.81189%Add 150%250,000
ARRYGeorge Soros 2011-03-31 Buy $2.7 - $3.29
($3)
$ 7.81160%New holding, 14400 sh.14,400
ARRYJean-Marie Eveillard 2011-03-31 Buy $2.7 - $3.29
($3)
$ 7.81160%New holding, 100000 sh.100,000
ARRYJean-Marie Eveillard 2010-09-30 Sold Out -0.01%$2.67 - $3.44
($3.02)
$ 7.81159%Sold Out0
ARRYJean-Marie Eveillard 2010-06-30 Reduce-0.01%$2.66 - $4.02
($3.41)
$ 7.81129%Reduce -54.96%450,000
ARRYJean-Marie Eveillard 2009-12-31 Add0.01%$1.72 - $2.81
($2.2)
$ 7.81255%Add 62.96%999,132
ARRYJean-Marie Eveillard 2008-12-31 Add0.02%$3.23 - $4.92
($3.9)
$ 7.81100%Add 102.65%573,865
ARRYJean-Marie Eveillard 2008-09-30 Reduce-0.01%$5.18 - $8.51
($7.3)
$ 7.817%Reduce -33.86%283,181
ARRYJean-Marie Eveillard 2008-06-30 Add0.01%$4.66 - $7.13
($6)
$ 7.8130%Add 62.74%428,181
ARRYJean-Marie Eveillard 2008-03-31 Add$5.36 - $8.1
($6.4)
$ 7.8122%Add 128.78%263,100
ARRYJean-Marie Eveillard 2007-12-31 Add$8.5 - $12.15
($10.7)
$ 7.81-27%Add 76.92%115,000
ARRYJean-Marie Eveillard 2007-09-30 Buy 0.01%$9.72 - $12.76
($11.4)
$ 7.81-32%New holding, 65000 sh.65,000
ARRYJean-Marie Eveillard 2007-06-30 Sold Out -0.01%$11.46 - $14
($12.7)
$ 7.81-38%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARRY is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ARRY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BVF PARTNERS L P/IL10% Owner 2014-06-25Sell0$0view
MOORE JOHN RVP, General Counsel 2013-11-29Sell11,666$5.7934.89view
MOORE JOHN RVP, General Counsel 2013-11-13Sell200$5.7934.89view
Ratcliffe LiamDirector 2013-09-27Sell1,125,728$630.17view
Ratcliffe LiamDirector 2013-09-16Sell1,673,172$6.0828.45view
Ratcliffe LiamDirector 2013-09-06Sell577,286$5.7934.89view
MOORE JOHN RVP, General Counsel 2013-08-02Sell75,384$7.0211.25view
MOORE JOHN RVP, General Counsel 2013-07-23Sell5,000$6.520.15view
BVF PARTNERS L P/IL10% Owner 2012-11-09Sell0$020.15view
MOORE JOHN RVP, General Counsel 2012-10-08Sell28,547$5.6937.26view

Press Releases about ARRY :

    Quarterly/Annual Reports about ARRY:

    News about ARRY:

    Articles On GuruFocus.com
    comment on ARRY Mar 02 2013 
    Re: ARRY Aug 29 2011 
    Drug Penny Stock Aug 23 2011 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,310 Shares Mar 16 2011 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,403 Shares Feb 11 2011 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,272 Shares Jan 13 2011 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,256 Shares Dec 10 2010 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,220 Shares Nov 12 2010 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,225 Shares Oct 13 2010 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,309 Shares Jul 23 2010 

    More From Other Websites
    Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2015 On February 3,... Jan 26 2015
    Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2015 On February 3,... Jan 26 2015
    8:00 am Array Biopharma has reached a definitive agreement with Novartis (Jan 25 2015
    Array BioPharma shares jump on news of Novartis cancer-drug deal Jan 23 2015
    Equities end the day mixed... Jan 23 2015
    Array shares jump after drugmaker details Novartis deal Jan 23 2015
    Array shares jump after drugmaker details Novartis deal Jan 23 2015
    Why Shares Of Array Biopharma Are Surging More Than 35% Jan 23 2015
    ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jan 23 2015
    Array Announces Agreement To Acquire ENCORAFENIB (LGX818) Jan 23 2015
    Array Announces Agreement To Acquire ENCORAFENIB (LGX818) Jan 23 2015
    Why You Shouldn't Bet Against Array BioPharma (ARRY) Stock - Tale of the Tape Jan 21 2015
    Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference Jan 08 2015
    Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference Jan 08 2015
    ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Dec 12 2014
    Oncothyreon Announces Exclusive License Agreement With Array BioPharma for ONT-380 Dec 12 2014
    The Zacks Analyst Blog Highlights: Cubist Pharmaceuticals, bluebird bio, Amgen, Incyte and Array Dec 11 2014
    Array BioPharma (ARRY) Shares March Higher, Can It Continue? Dec 05 2014
    Array BioPharma, Inc. (ARRY) in Focus: Stock Soars 14.3% Dec 05 2014
    Array BioPharma Regains Binimetinib Rights from Novartis Dec 04 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK